Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Clinical trial NCT01158170 · UNKNOWN

Trial details

NCT number: NCT01158170
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2010-06-01
Primary completion: 2013-05-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.